Shots: RetinAI signs a multi-year collaboration with Novartis under which RetinAI’s IT solutions and AI tools will be employed to support multiple projects in ophthalmology and digital health The first […]readmore
Tags : Ophthalmology
Shots: EMA has accepted to review the MAA for SB11, a proposed biosimilar referencing Lucentis (ranibizumab). If approved, SB11 will join a growing number of biosimilars developed by Samsung Bioepis […]readmore
Shots: Aerie to acquire Avizorex (AVX) in an all-cash transaction. Avizorex to receive $10M up front, development & regulatory milestones with royalties in sales of the approved product in its […]readmore
Shots: AbbVie to acquire Allergan in cash & stock transaction making the total deal value $63B, based on the closing price of AbbVie’s common stock of $78.45 on June 24, […]readmore